Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ATB-346 is a non-steroidal anti-inflammatory drug (NSAID) that releases hydrogen sulfide (H2S) and a derivative of naproxen (Item No. 70290).1 It inhibits the proliferation of, and induces apoptosis in, A375 melanoma cells when used at a concentration of 100 µM.2 ATB-346 decreases prostaglandin E2 (PGE2) production in inflammatory exudates, reduces paw edema, and increases plasma levels of sulfide in a mouse model of zymosan-induced arthritis.1,3 It reduces the size of acetic acid-induced gastric ulcers in mice when administered at a dose of 60 µmol/kg.1 ATB-346 (30 µmol/kg) improves motor function in a mouse model of spinal cord injury.4
WARNING This product is not for human or veterinary use.
1. Markedly reduced toxicity of a hydrogen sulphide-
2. ATB-
3. Hydrogen sulfide releasing naproxen offers better anti-
4. A hydrogen sulfide-